| Data | Ora | Fonte | Titolo | Simbolo | Compagnia |
| 17/10/2017 | 19:28 | Edgar (US Regulatory) | Termination of Registration of a Class of Security Under Section 12(g) (15-12g) | AMEX:AXN | Aoxing Pharmaceutical Company New (delisted) |
| 06/10/2017 | 22:17 | Edgar (US Regulatory) | (25) | AMEX:AXN | Aoxing Pharmaceutical Company New (delisted) |
| 06/10/2017 | 12:03 | Edgar (US Regulatory) | Notice of Effectiveness (effect) | AMEX:AXN | Aoxing Pharmaceutical Company New (delisted) |
| 29/09/2017 | 12:04 | Edgar (US Regulatory) | Withdrawal of Registration Statement (ammendment) (aw) | AMEX:AXN | Aoxing Pharmaceutical Company New (delisted) |
| 28/09/2017 | 12:04 | Edgar (US Regulatory) | Notification That Annual Report Will Be Submitted Late (nt 10-k) | AMEX:AXN | Aoxing Pharmaceutical Company New (delisted) |
| 27/09/2017 | 21:10 | Edgar (US Regulatory) | Post-effective Amendment to Registration Statement (pos Am) | AMEX:AXN | Aoxing Pharmaceutical Company New (delisted) |
| 26/09/2017 | 17:03 | Edgar (US Regulatory) | Securities Registration Statement (simplified Form) (s-3/a) | AMEX:AXN | Aoxing Pharmaceutical Company New (delisted) |
| 25/09/2017 | 12:02 | Edgar (US Regulatory) | Current Report Filing (8-k) | AMEX:AXN | Aoxing Pharmaceutical Company New (delisted) |
| 15/05/2017 | 14:39 | Edgar (US Regulatory) | Quarterly Report (10-q) | AMEX:AXN | Aoxing Pharmaceutical Company New (delisted) |
| 11/05/2017 | 16:21 | Edgar (US Regulatory) | Additional Proxy Soliciting Materials (definitive) (defa14a) | AMEX:AXN | Aoxing Pharmaceutical Company New (delisted) |
| 11/05/2017 | 16:20 | Edgar (US Regulatory) | Proxy Statement (definitive) (def 14a) | AMEX:AXN | Aoxing Pharmaceutical Company New (delisted) |
| 17/02/2017 | 18:34 | Edgar (US Regulatory) | Amended Quarterly Report (10-q/a) | AMEX:AXN | Aoxing Pharmaceutical Company New (delisted) |
| 05/10/2016 | 22:33 | Edgar (US Regulatory) | Annual Report (10-k) | AMEX:AXN | Aoxing Pharmaceutical Company New (delisted) |
| 08/02/2016 | 14:30 | PR Newswire (US) | Aoxing Pharmaceuticals Q2 Revenue Up 27%; Net Income $2.1 Million, Up 265% | AMEX:AXN | Aoxing Pharmaceutical Company New (delisted) |
| 01/02/2016 | 14:30 | PR Newswire (US) | Aoxing Pharma Appoints Dr. James Chen as Chief Financial Officer | AMEX:AXN | Aoxing Pharmaceutical Company New (delisted) |
| 10/12/2015 | 14:30 | PR Newswire (US) | Aoxing Pharma Selected to Supply Zhongtongan to the Insurance System for the City of Shanghai | AMEX:AXN | Aoxing Pharmaceutical Company New (delisted) |
| 04/12/2015 | 14:30 | PR Newswire (US) | Aoxing Pharma Announces Opening Of Government Funded Drug Research Center | AMEX:AXN | Aoxing Pharmaceutical Company New (delisted) |
| 04/12/2015 | 14:00 | PR Newswire (US) | Aoxing Pharma Announces Resignation of CFO | AMEX:AXN | Aoxing Pharmaceutical Company New (delisted) |
| 03/12/2015 | 16:38 | PR Newswire (US) | SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Aoxing Pharmaceutical Company, Inc. | AMEX:AXN | Aoxing Pharmaceutical Company New (delisted) |
| 03/12/2015 | 00:27 | PR Newswire (US) | SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Aoxing Pharmaceutical, Inc. - AXN | AMEX:AXN | Aoxing Pharmaceutical Company New (delisted) |
| 13/11/2015 | 14:30 | PR Newswire (US) | Aoxing Pharmaceuticals Q1 Revenue Up 92 Percent; Net Income Of $1.35 Million | AMEX:AXN | Aoxing Pharmaceutical Company New (delisted) |
| 28/09/2015 | 22:14 | Edgar (US Regulatory) | Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) | AMEX:AXN | Aoxing Pharmaceutical Company New (delisted) |
| 28/07/2015 | 15:10 | PR Newswire (US) | Drug Manufacturers - Major Stocks on the Move -- GlaxoSmithKline, Sanofi, Aerie Pharma, TherapeuticsMD, and Aoxing Pharma | AMEX:AXN | Aoxing Pharmaceutical Company New (delisted) |
| 22/06/2015 | 23:15 | Edgar (US Regulatory) | Securities Registration Statement (simplified Form) (s-3) | AMEX:AXN | Aoxing Pharmaceutical Company New (delisted) |
| 09/02/2015 | 20:31 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | AMEX:AXN | Aoxing Pharmaceutical Company New (delisted) |
| 09/02/2015 | 19:58 | Edgar (US Regulatory) | Initial Statement of Beneficial Ownership (3) | AMEX:AXN | Aoxing Pharmaceutical Company New (delisted) |
| 17/06/2014 | 02:26 | Marketwired | Aoxing Pharmaceutical Company, Inc. Receives Notice of Extension From NYSEMKT LLC | AMEX:AXN | Aoxing Pharmaceutical Company New (delisted) |
| 14/05/2014 | 23:45 | Marketwired | Aoxing Pharmaceutical Company, Inc. Announces Financial Results for Third Quarter of 2014 Fiscal Year | AMEX:AXN | Aoxing Pharmaceutical Company New (delisted) |
| 04/03/2014 | 23:30 | Marketwired | Aoxing Pharmaceutical Company, Inc. Receives Notice of Extension and Additional Notice of Noncompliance From NYSEMKT LLC | AMEX:AXN | Aoxing Pharmaceutical Company New (delisted) |
| 19/02/2014 | 18:15 | Marketwired | Aoxing Pharmaceutical Company, Inc. Announces Financial Results for Second Quarter of 2014 Fiscal Year | AMEX:AXN | Aoxing Pharmaceutical Company New (delisted) |